Innovative Approximate Analytical Solution for Standard Model of Viral Dynamics: Hepatitis C with Direct-Acting Agents as an Implemented Case
暂无分享,去创建一个
[1] Tsuyoshi Murata,et al. {m , 1934, ACML.
[2] Eugene R. Schiff,et al. National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C , 1997, Hepatology.
[3] H. Elkaranshawy,et al. Modified Parker-Sochacki method for solving nonlinear oscillators , 2017 .
[4] William M. Lee,et al. Interferon Alfa-2 b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C , 2015 .
[5] William M. Lee,et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.
[6] Aaas News,et al. Book Reviews , 1893, Buffalo Medical and Surgical Journal.
[7] M A Nowak,et al. The dynamics of hepatitis B virus infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[8] A. Neumann,et al. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics. , 2010, Journal of theoretical biology.
[9] H. Vázquez-Leal,et al. Application of series method with Padé and Laplace-Padé resummation methods to solve a model for the evolution of smoking habit in Spain , 2014 .
[10] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[11] D. S. Jones,et al. Differential Equations and Mathematical Biology , 1983 .
[12] Yanni Xiao,et al. Global Dynamics of a Virus-Immune System with Virus-Guided Therapy and Saturation Growth of Virus , 2018, Mathematical Problems in Engineering.
[13] Alan S. Perelson,et al. Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model , 2013, PLoS Comput. Biol..
[14] Thi Huyen Tram Nguyen,et al. Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens , 2017, PloS one.
[15] Wen-Hsien Ho,et al. Hybrid Taguchi-Differential Evolution Algorithm for Parameter Estimation of Differential Equation Models with Application to HIV Dynamics , 2011 .
[16] H. Elkaranshawy,et al. Power Series Solution to Sliding Velocity in Three-Dimensional Multibody Systems with Impact and Friction , 2015 .
[17] Martin A Nowak,et al. Mathematical models of HIV pathogenesis and treatment. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.
[18] G. A. Baker,et al. Padé Approximants Second Edition: Extensions of Padé approximants , 1996 .
[19] M. Manns,et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. , 2002, Gastroenterology.
[20] T. Ayer,et al. Hepatitis C virus re‐treatment in the era of direct‐acting antivirals: projections in the USA , 2018, Alimentary pharmacology & therapeutics.
[21] S. Lenhart,et al. The Dynamics of HPV Infection and Cervical Cancer Cells , 2015, Bulletin of Mathematical Biology.
[22] H. Elkaranshawy,et al. Extended Parker-Sochacki method for Michaelis-Menten enzymatic reaction model. , 2016, Analytical biochemistry.
[23] Libin Rong,et al. Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life , 2013, Proceedings of the National Academy of Sciences.
[24] Libin Rong,et al. Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents. , 2013, Mathematical biosciences.
[25] Danna Zhou,et al. d. , 1934, Microbial pathogenesis.
[26] L. Henry,et al. Sofosbuvir (Sovaldi) for the treatment of hepatitis C , 2014, Expert review of clinical pharmacology.
[27] Alan S. Perelson,et al. Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy , 1998 .
[29] Ahmet Yildirim,et al. Series solution of a nonlinear ODE arising in magnetohydrodynamic by HPM-Padé technique , 2011, Comput. Math. Appl..
[30] Alan S. Perelson,et al. Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and Interleukin-28B , 2011 .
[31] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[32] Anushree Chatterjee,et al. Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents? , 2012, Antiviral therapy.
[33] Patrick Levoir,et al. Direct analysis of chemical relaxation signals by a method based on the combination of Laplace transform and Padé approximants , 1987, Comput. Chem..
[34] T. Asselah,et al. New direct‐acting antivirals' combination for the treatment of chronic hepatitis C , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[35] Thi Huyen Tram Nguyen,et al. The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics? , 2017, Scientific Reports.
[36] S. Effati,et al. Multiobjective Optimal Control of HIV Dynamics , 2010 .
[37] Lequan Min,et al. Mathematical Analysis of a Basic Virus Infection Model With Application to HBV Infection , 2008 .